NCT01259063 RAD001 and Intravesical Gemcitabine in BCG-Refractory Primary or Secondary Carcinoma In Situ of the Bladder Status COMPLETED Phase PHASE1/PHASE2
NCT01257815 Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment Status COMPLETED Phase PHASE4
NCT01257451 Safety and Efficacy of Galvus in Elderly Type 2 Diabetes Patients Status COMPLETED Phase PHASE3
NCT01257126 Efficacy of Diclofenac Potassium vs Nimesulide in the Treatment of Fever and Pain in Children With Upper Respiratory Tract Infection Status WITHDRAWN Phase PHASE4
NCT01256411 A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential Hypertension Status COMPLETED Phase PHASE2
NCT01255462 Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration Status COMPLETED Phase PHASE1
NCT01254227 Efficacy and Safety of Deferasirox in Combination With Deferoxamine Followed by Deferasirox Monotherapy in Severe Cardiac Iron Overload Status COMPLETED Phase PHASE2
NCT01254188 Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients Status COMPLETED Phase PHASE3
NCT01253629 Safety and Efficacy of AFQ056 in Adult Patients With Fragile X Syndrome Status COMPLETED Phase PHASE2
NCT01253161 Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs) Status COMPLETED Phase PHASE2
NCT01252251 RAD001 (Everolimus) and Pasireotide (SOM230) LAR in Patients With Advanced Uveal Melanoma Status COMPLETED Phase PHASE2
NCT01250951 This Study Will Evaluate Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndromes (MDS), Thalassemia and Rare Anemia Types Having Transfusion-induced Iron Overload. Status COMPLETED Phase PHASE4
NCT01250171 The Effects of a Single Intravenous Administration of Secukinumab (AIN457) or Canakinumab (ACZ885) in Dry Eye Patients Status COMPLETED Phase PHASE2
NCT01249456 Safety and Efficacy Study of Femara(Letrozole) as an Extended Adjuvant Treatment in Breast Cancer Patients Status COMPLETED Phase N/A
NCT01243944 Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) Tablets Versus Best Available Care: (The RESPONSE Trial) Status COMPLETED Phase PHASE3
NCT01242813 Efficacy and Safety Study of ACZ885 in Patients With Active Recurrent or Chronic TNF-receptor Associated Periodic Syndrome (TRAPS). Status COMPLETED Phase PHASE2
NCT01242774 Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML) Status COMPLETED Phase PHASE1
NCT01240655 A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01240642 An Open-label, Dose Escalation Multi-center Study in Patients With Advanced Cancer to Determine the Infusion Rate Effect of ASA 404 With Paclitaxel Plus Carboplatin Regimen or Docetaxel on the Pharmacokietics of Free and Total ASA404 Status TERMINATED Phase PHASE1